Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Juvenile 2Inflammation 2Asthma 2Wilms Tumor 1Vasculitis 1Uveitis 1Temporomandibular Joint Disorders 1Stomatitis 1Spondylitis, Ankylosing 1Respiratory Distress Syndrome 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lupus Nephritis 1Lung Injury 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Immunoglobulin Light-chain Amyloidosis 1Granulomatosis with Polyangiitis 1Fatigue Syndrome, Chronic 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Bronchiolitis Obliterans 1Blast Crisis 1

Interventions

Cisplatin 6Radiotherapy, Intensity-Modulated 4Saline Solution 3Injections 3golotimod 2avasopasem manganese 2Water 2Vitamin B 12 2Standard of Care 2RRx-001 2Practice Guidelines as Topic 2Gentamicins 2Fibroblast Growth Factor 7 2FGF20 protein, human 2Drug Therapy 2samital 1regramostim 1peppermint oil 1meclocycline 1hydrated silica gel-based toothpaste 1holy basil leaf extract 1cobiprostone 1clazakizumab 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Stomatitis × Etanercept × Clear all
NCT00031551 2017-12-06

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
27 enrolled 10 charts

Inflammation, Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡